Third jab ‘significantly’ boosts Omicron antibodies: AstraZeneca
Clues to treatment of schizophrenia and bipolar disorder found in recently evolved region of the ‘dark genome’
23 December 2021German health minister expects virus surge around New Year’s
23 December 2021Third jab ‘significantly’ boosts Omicron antibodies: AstraZeneca
British pharmaceutical giant AstraZeneca said Thursday that a third, or “booster”, dose of its COVID-19 vaccine Vaxzevria “significantly” lifted antibody levels against the Omicron strain in a laboratory study.
